Navigation Links
OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences
Date:3/22/2012

SAN DIEGO, March 22, 2012 /PRNewswire/ -- OncoSec Medical Incorporated. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences. Data from the Phase IV study carried out in Europe has been selected for a poster session and special oral presentation at the 5th European Conference on Head and Neck Oncology. In addition, data from the Phase III study carried out in the United States has been selected for a poster presentation at the 8th International Head and Neck Cancer Conference.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

OncoSec's most advanced stage treatment platform, OMS ElectroChemotherapy, is a targeted ablation therapy, which utilizes the OMS to locally deliver bleomcyin to the tumor. This treatment platform preferentially kills targeted cancer cells while sparing surrounding normal healthy tissue. OMS ElectroChemotherapy has been developed up to Phase III clinical trials in the United States for the treatment of recurrent head and neck cancer and in Phase I/II for the treatment of recurrent breast cancer. In addition, Phase IV pre-marketing studies to support the commercialization of the OMS system in Europe were also performed for the treatment of primary and recurrent head and neck cancers and cutaneous skin cancers.

"Since acquiring the OMS ElectroChemotherapy assets in March 2011, we have been working diligently to compile and analyze data from the Phase III and IV studies carried out in the United States and Europe. We are excited that we will now have the opportunity to share this data with the public in the coming months," said Punit Dhillon, President and CEO. "
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
4. OncoSec Medical Closes $1.1M Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
7. OncoSec Medical Appoints Engineering Leader
8. OncoSec Medical to Present at Industry and Investor Conferences
9. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
10. OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials
11. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... and LONDON , August 26, 2014 ... FDNA Inc. ( http://www.fdna.com ) and London Medical Databases ... partnered to offer, for the first time, online access ... FDNA, developer of the Facial Dysmorphology ... collection into Face2Gene [ TM ] , ...
(Date:8/26/2014)... SAN DIEGO , Aug. 26, 2014   ... M.D., has been named vice president, clinical development, and ... president, clinical operations. "As we advance ... we are expanding our clinical team with individuals who ... and commercialization activities," said Jamey Skillings , M.D., ...
(Date:8/26/2014)... , Aug. 26, 2014  Zimmer Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2014. The cash dividend of ... 31, 2014, to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
Breaking Medicine Technology:FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3Tocagen Expands Clinical Development Team; 2Tocagen Expands Clinical Development Team; 3
... N.J., July 26, 2011 Watson Pharmaceuticals, Inc. ... definitive agreement to acquire a portfolio of generic ... result of the merger between Perrigo Company and ... including four FDA-approved products and two undisclosed development-stage ...
... N.J., July 26, 2011 The Board of Directors of ... a leading global medical technology company, today announced that, in ... A. Forlenza as Chief Executive Officer and President, effective October ... the Board at that time. Also effective October 1, current ...
Cached Medicine Technology:Watson Enters into Agreement to Acquire Products Related to Perrigo's Acquisition of Paddock Laboratories 2BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011 2BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011 3
(Date:8/27/2014)... (PRWEB) August 27, 2014 iHire ... practices as the “Most Creative Workplace” in Frederick, ... Best Places to Work Awards. , Held at ... event is a joint partnership between the Frederick ... Economic Development, Frederick County Business Development and Retention, ...
(Date:8/26/2014)... August 27, 2014 Carol Fenster, a ... 100 Best Quick Gluten-Free Recipes (Houghton Mifflin Harcourt, ... , Fenster believes that cooking gluten-free food can ... today’s busy lifestyle doesn’t leave much time for food ... cooks ask me is how to shorten their time ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 There are ... affluent, however the reality is cruel. Some people, especially ... clothes, may not save enough money to be affluent. ... is delighted to announce its new catalog, Flash Deals ... dresses, bags, outdoor accessories and more from this company ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Gel-E Donut and ... August 22, that Gel-E Donut and Squishon 2 gel-filled products, ... complaints about visible mold. Gel E-Donut and Squishon 2 are ... and/or body, help ease pressure caused by long periods of ...
(Date:8/26/2014)... TX (PRWEB) August 26, 2014 ... it simply makes sense to use hearing protection ... losing hearing forever. There are many different forms ... Employers generally provide hearing protection training and devices ... other noisy industries. The National Institute of Occupational ...
Breaking Medicine News(10 mins):Health News:iHire Named Most Creative Workplace in Frederick, MD 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 2Health News:Gluten-Free Expert Carol Fenster Announces New Cookbook for Quick Meals 3Health News:Become a Rich Person Right Away By Taking Advantage Of Fecbek.com's Flash Deals 2Health News:Gel-E Donut and Squishon 2 Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:San Antonio Hearing Centers Now Offering a Full Line of Occupational Hearing Protection Products 2Health News:San Antonio Hearing Centers Now Offering a Full Line of Occupational Hearing Protection Products 3
... Cholesterol-lowering drugs known as statins are among the ... study by researchers at Fred Hutchinson Cancer Research Center ... from one of the most serious complications of the ... are reported in the Nov. 4 first edition of ...
... ... Product in Scottsdale , ... (Vocus) December 4, 2009 -- A valley inventor garnering national attention with an ... boost productivity will be showcasing the product at Saturday’s Technology Fair located at the ...
... , WASHINGTON, Dec. 4 As Congress ... Research Council (FRC) today announced an eight week campaign to ... on provisions of the Senate health care bill. These ... or the public option. Survey participants who express opposition ...
... JEFFERSON CITY, Mo., Dec. 4 Farmers Insurance Missouri State Executive ... the CEO and creator of a children,s fire safety program sponsored ... conduct a children,s fire safety day at the Missouri Capitol December ... call for fire safety comes following a tragic fire that took ...
... Journal of Neurosurgery: Pediatrics finds that operative plans ... thalamus of the brain can be augmented with Diffusion Tensor ... for the visualization of nerve fiber bundles in the brain. ... the tumor while avoiding damage to the fiber bundles that ...
... ... to enhance consumers’ quality of life, today announced that it has been awarded the ... HealthiFeet®. , ... (PRWEB) December 4, 2009 -- Tender Corp., a leading manufacturer of over-the-counter topical cream ...
Cached Medicine News:Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2Health News:Missouri Safety Day at the Capitol 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Ident-A-Drug gives you quick accurate identification of oral tablets and capsules used in North America....
... latest in scientific clinical trial activity and ... resources from CenterWatch. This highly valuable resource ... and stay abreast of medical breakthroughs on ... Trials, Clinical Trial Results, Newly Approved Drugs, ...
Providing patients and their advocates with a variety of information services and educational materials on clinical research....
Medicine Products: